ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Similar Stocks

Compare
2,293 Followers

Comparison Results

Name
Price
Analyst Price Target
Analyst Consensus
Market Cap
P/E Ratio
Yearly Gain
Top Analysts' Price Target
Smart Score
Follow
ACADIA Pharmaceuticals
$15.38
9 Buy
6 Hold
0 Sell
Moderate Buy
$2.69B
11.31
-14.60%
Neurocrine
$95.65
17 Buy
5 Hold
0 Sell
Strong Buy
$10.26B
29.06
-31.15%
Prothena
$10.86
6 Buy
2 Hold
0 Sell
Strong Buy
$584.56M
-53.53%
Intra-Cellular Therapies
$131.87
4 Buy
9 Hold
0 Sell
Moderate Buy
$14.05B
92.68%
SAGE Therapeutics
$6.86
2 Buy
14 Hold
1 Sell
Hold
$421.76M
-58.22%
Axsome Therapeutics
$98.86
17 Buy
0 Hold
0 Sell
Strong Buy
$5.26B
36.83%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACAD
ACADIA Pharmaceuticals
15.38
-2.42
-13.60%
NBIX
Neurocrine
95.65
-43.79
-31.40%
PRTA
Prothena
10.86
-12.82
-54.14%
ITCI
Intra-Cellular Therapies
131.87
64.17
94.79%
SAGE
SAGE Therapeutics
6.86
-9.74
-58.67%
AXSM
Axsome Therapeutics
98.86
26.75
37.10%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis